Related Experiment Video
Updated: Jul 14, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae
Christina Kratzer1, Wolfgang Graninger, Karin Macfelda
1Department of Internal Medicine I, Division of Infectious Diseases and Tropical Diseases, Medical University of Vienna, Vienna, Austria.
Introduction:
Non-typeable Haemophilus influenzae (NTHi) is a major bacterial pathogen of community-acquired respiratory tract infection and is usually found extracellularly, although studies have revealed that NTHi may possess the ability to invade human epithelial cells where it is then protected against attack by the local immune system and partly against the effect of antibiotics. The aim of the present study was to assess the ability of ampicillin, azithromycin, telithromycin, ciprofloxacin and moxifloxacin, five antibiotics in common clinical use, to kill NTHi within bronchial epithelial cells.
Methods:
Confluent human bronchial epithelial cells were infected with NTHi 77, a particularly invasive clinical strain. Extracellular bacterial cells were killed with gentamicin and the intracellular bacteria were incubated with antibiotics at concentrations of 1 mg/l or 10 mg/l for 4 h or 8 h. Viable intracellular bacteria were counted after lysis of the epithelial cells.
Results:
With the exception of ampicillin, all the antibiotics caused significant reduction of intracellular bacteria at concentrations of 10 mg/l and exposure for 4 h or at 1 mg/l for 8 h. At 1 mg/l, moxifloxacin eliminated 94% of intracellular NTHi after 4 h and 98% after 8 h; ciprofloxacin, azithromycin and telithromycin only achieved killing indices below 75 after 4 h but 86-90% killing after 8 h. At 10 mg/l, moxifloxacin, ciprofloxacin, telithromycin and azithromycin were able to achieve 99.7%, 96.3%, 86.7% and 74.7% eradication of intracellular bacteria, respectively, after exposure for 4 h.
Conclusion:
These results demonstrate the rapid antibacterial efficacy of moxifloxacin against intracellular NTHi in vitro. Moxifloxacin, which combines high extracellular and intracellular activities, could be an important tool in the treatment of recurrent respiratory tract infections.
Insights
Moxifloxacin effectively kills intracellular non-typeable Haemophilus influenzae (NTHi), a common respiratory pathogen. This antibiotic shows rapid efficacy, making it a potential treatment for recurrent NTHi infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Non-typeable Haemophilus influenzae (NTHi) is a significant cause of respiratory infections.
- NTHi can invade epithelial cells, evading immune responses and antibiotics.
- Understanding intracellular NTHi activity is crucial for effective treatment.
Purpose of the Study:
- To evaluate the efficacy of five common antibiotics against intracellular NTHi.
- To compare the killing activity of ampicillin, azithromycin, telithromycin, ciprofloxacin, and moxifloxacin.
- To determine the impact of antibiotic concentration and exposure time on intracellular NTHi viability.
Main Methods:
- Human bronchial epithelial cells infected with NTHi 77.
- Treatment with antibiotics (ampicillin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin) at 1 mg/l or 10 mg/l for 4 or 8 hours.
- Quantification of viable intracellular bacteria after cell lysis.
Main Results:
- Moxifloxacin demonstrated rapid and significant reduction of intracellular NTHi.
- At 1 mg/l, moxifloxacin achieved 94-98% killing within 4-8 hours.
- At 10 mg/l, moxifloxacin, ciprofloxacin, and telithromycin showed high efficacy (74.7-99.7%) after 4 hours.
Conclusions:
- Moxifloxacin exhibits potent in vitro activity against intracellular NTHi.
- Its combined extracellular and intracellular efficacy suggests potential for treating recurrent respiratory infections.
- Further investigation into moxifloxacin's role in NTHi treatment is warranted.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017